| 发明名称 |
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| 摘要 |
The present invention involves the administration of Copolymer 1 (glatiramer acetate) to treat inflammatory, non-autoimmune central nervous system (CNS) diseases, alleviate the symptoms thereof, inhibit the activity of matrix metalloproteinases and suppress cytokine production by T lymphocytes.
|
| 申请公布号 |
US7033582(B2) |
申请公布日期 |
2006.04.25 |
| 申请号 |
US20040920136 |
申请日期 |
2004.08.17 |
| 申请人 |
TEVA PHARMACEUTICAL INDUSTRIES, LTD. |
发明人 |
YONG V. WEE;CHABOT SOPHIE |
| 分类号 |
A61K38/00;A61K9/00;A61K9/10;A61K9/20;A61K9/48;A61K31/785;A61K38/02 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
